Sale

Nebulizer Market

Global Nebulizer Market Share, Size, Trends, Demand, Growth: By Product Type: Jet Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer; By Portability: Digital Nebulizer, Analog Nebulizer; By Applications: COPD, Cystic Fibrosis, Asthma, Others; By End User: Hospitals, Clinics, Homecare Settings, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Nebulizer Market Outlook

The global nebulizer market size was valued at USD 1.14 billion in 2023, driven by the increasing prevalence of respiratory diseases across the globe. The market is expected to grow at a CAGR of 6% during the forecast period of 2024-2032, with the values likely to rise from USD 1.21 billion in 2024 to USD 1.93 billion by 2032.

 

nebulizer market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Nebulizer Market Overview

Nebulizers find their application to treat multiple indications such as asthma, COPD, and cystic fibrosis. Due to the high prevalence of smoking, and rapid industrialization, pollution levels are on the rise and there has been a significant upswing in respiratory disorders. Incidence of chronic diseases such as (chronic obstructive pulmonary disease) COPD is constantly on the rise and is expected to affect around 600 million  people globally by 2050, leading to a substantial surge in the nebulizer market demand in the forecast period.

 

The market is driven by an increasing incidence of product launches focused on design improvements to offer customized and improved solutions to the patients. In addition, growing awareness of respiratory illnesses and the increasing accessibility of nebulizers are driving the growth along with Increasing investments by the key market players in the research and development of several new nebulizers with cutting-edge features.

 

Rising Prevalence for Portable Nebulizers

With increasing advancements in medical device manufacturing and a rising integration of novel technologies in the healthcare ecosystem, there has been significant nebulizer market growth with the development of new devices. In January 2023, Synergy Life Science, Inc.,  launched Nebi, the first battery operated and compact nebuliser to be used for multiple respiratory indications. To beat the issues related to conventional nebulizers, the new device is equipped with a rechargeable battery, and is based on interchangeable, and replaceable cartridges. It can also be used in cannabis, wellness, and smoking cessation therapies and possesses the potential to be used in multiple treatments.

 

Surge Research Activities to Develop IoT based Nebulizers and Boost Nebulizers Market Share

To offer precise and timely drug dosage, scientists have developed an IoT based nebulizer which work by providing an intelligent airflow. Breath Enhanced Technology (BET)  is used in modern commercial nebulizers, as it offers controlled drug delivery and monitors asthma attacks with respect to frequency and time. With prompt monitoring, patients can receive improved treatment and prevention from fatal complications as well. The new technology offers an advantage over normal circuits, which are a more tedious process to manage.

 

Increasing Investments to Develop New Devices

In October 2022, Qnovia secured USD 17 million funding to develop an effective nicotine replacement therapy for humans with the help of a breath-activated, hand-held vibrating mesh nebulizer that generates aerosol for inhalation. The rising investments to bring improved and effective patient outcomes to poised to expand the nebulizer market size in the forecast period. The company aimed at developing an effective device that offers precise dosage along with optimal delivery to the lungs. With multiple partnerships, the company also plans to expand their research and offer treatment for multiple respiratory indications.

 

nebulizer market by Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Nebulizer Market Segmentation

Market Breakup by Product Type

  • Jet Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer

 

Market Breakup by Portability
 

  • Digital Nebulizer
  • Analog Nebulizer

 

Market Breakup by Applications

  • COPD
  • Cystic Fibrosis
  • Asthma
  • Others

 

Market Breakup by End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

nebulizer market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Nebulizer Market Regional Analysis

The United States is expected to lead the market share in coming years. The market share can be attributed to a robust medical and research infrastructure. The presence of prominent healthcare companies, along with academic and research institutions, plays a pivotal role in driving the market value.

 

In the forecast period, Asia Pacific region is poised to experience significant nebulizer market growth, with countries like China, India, and Japan emerging as the biggest markets. The growth can be attributed to the increasing prevalence of respiratory disorders such as COPD, asthma, and cystic fibrosis and rising merger activities between native and international companies. For instance, AeroRx Therapeutics  (a United States based inhalation company) and a Taiwan based startup, HCmed Innovations collaborated to develop a breath-actuated nebulizer in combination with LABA/LAMA (long-acting muscarinic antagonist/long-acting beta agonist).

 

Global Nebulizer Market: Competitor Landscape

In June 2023, Liquidia Corporation and Pharmosa Biopharm  announced their collaboration to develop and commercialise L606, a controlled release and inhalation-based formulation of Treprostinil, under clinical trial evaluation for treating pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The collaboration is anticipated to cost around USD 10 million and as per the terms of agreement, Liquidia is expected to develop and take control of the regulatory and commercial activities while Pharmosa will help in establishing a global supply chain and manufacture clinical and commercial supplies. The market has been witnessing several mergers and acquisitions amongst developed and budding organizations to diversify their product portfolio and establish a solid market presence.

 

The key features of the nebulizer market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Adherium
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc.
  • GSK Group of Companies
  • Teva Pharmaceutical Industries Limited
  • Vectura Group Ltd.
  • Propeller Health
  • Novartis AG
  • OPKO Health Inc.
  • AptarGroup, Inc.
  • Sensirion AG
  • Teleflex Medical, Inc.
  • Trudell Medical International
  • Briggs Healthcare

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Portability
  • Applications
  • End User
  • Region
Breakup by Product Type
  • Jet Nebulizer 
  • Ultrasonic Nebulizer
  • Mesh Nebulizer
Breakup by Portability
  • Digital Nebulizer
  • Analog Nebulizer
Breakup by Applications
  • COPD
  • Cystic Fibrosis 
  • Asthma
  • Others
Breakup by End User
  • Hospitals
  • Clinics
  • Homecare Settings
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Adherium
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc.
  • GSK Group of Companies
  • Teva Pharmaceutical Industries Limited
  • Vectura Group Ltd.
  • Propeller Health
  • Novartis AG
  • OPKO Health Inc.
  • AptarGroup, Inc.
  • Sensirion AG
  • Teleflex Medical, Inc. 
  • Trudell Medical International
  • Briggs Healthcare

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Nebulizer Market Overview 

    3.1    Global Nebulizer Market Historical Value (2017-2023)  
    3.2    Global Nebulizer Market Forecast Value (2024-2032)
4    Global Nebulizer Market Landscape
    4.1    Global Nebulizer Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Nebulizer Product Landscape
        4.2.1    Analysis by Product Type 
        4.2.2    Analysis by Portability 
        4.2.3    Analysis by Applications  
5    Global Nebulizer Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Nebulizer Market Segmentation (2017-2032)  
    6.1    Global Nebulizer Market (2017-2032) by Product Type  
        6.1.1    Market Overview                                                       
        6.1.2    Jet Nebulizer 
        6.1.3    Ultrasonic Nebulizer
        6.1.4    Mesh Nebulizer
    6.2    Global Nebulizer Market (2017-2032) by Portability  
        6.2.1    Market Overview
        6.2.2    Digital Nebulizer
        6.2.3    Analog Nebulizer
    6.3    Global Nebulizer Market (2017-2032) by Applications  
        6.3.1    Market Overview 
        6.3.2    COPD
        6.3.3    Cystic Fibrosis 
        6.3.4    Asthma
        6.3.5    Others
    6.4    Global Nebulizer Market By End User
        6.4.1     Market Overview
        6.4.2    Hospitals
        6.4.3    Clinics
        6.4.4    Homecare Settings
        6.4.5    Others
    6.5    Global Nebulizer Market (2017-2032) by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Nebulizer Market (2017-2032)
    7.1    North America Nebulizer Market (2017-2032) by Product Type 
        7.1.1    Market Overview                                                             
        7.1.2    Jet Nebulizer 
        7.1.3    Ultrasonic Nebulizer
        7.1.4    Mesh Nebulizer  
    7.2      North America Nebulizer Market (2017-2032) by Portability 
        7.2.1    Market Overview
        7.2.2    Digital Nebulizer
        7.2.3    Analog Nebulizer
    7.3    North America Nebulizer Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Nebulizer Market (2017-2032)
    8.1    Europe Nebulizer Market (2017-2032) by Product Type  
        8.1.1    Market Overview                                                                 
        8.1.2    Jet Nebulizer 
        8.1.3    Ultrasonic Nebulizer
        8.1.4    Mesh Nebulizer 
    8.2      Europe Nebulizer Market (2017-2032) by Portability 
        8.2.1    Market Overview
        8.2.2    Digital Nebulizer
        8.2.3    Analog Nebulizer
    8.3    Europe Nebulizer Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Nebulizer Market (2017-2032)
    9.1    Asia Pacific Nebulizer Market (2017-2032) by Product Type 
        9.1.1    Market Overview                                                             
        9.1.2    Jet Nebulizer 
        9.1.3    Ultrasonic Nebulizer
        9.1.4    Mesh Nebulizer 
    9.2      Asia Pacific Nebulizer Market (2017-2032) by Portability  
        9.2.1    Market Overview
        9.2.2    Digital Nebulizer
        9.2.3    Analog Nebulizer
    9.3    Asia Pacific Nebulizer Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4   ASEAN 
        9.3.5    Others
10    Latin America Nebulizer Market (2017-2032)
    10.1    Latin America Nebulizer Market (2017-2032) by Product Type 
        10.1.1    Market Overview                                                           
        10.1.2    Jet Nebulizer 
        10.1.3    Ultrasonic Nebulizer
        10.1.4    Mesh Nebulizer 
    10.2      Latin America Nebulizer Market (2017-2032) by Portability 
        10.2.1    Market Overview
        10.2.2    Digital Nebulizer
        10.2.3    Analog Nebulizer
    10.3    Latin America Nebulizer Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Nebulizer Market (2017-2032)
    11.1    Middle East and Africa Nebulizer Market (2017-2032) by Product Type 
        11.1.1    Market Overview                                                               
        11.1.2    Jet Nebulizer 
        11.1.3    Ultrasonic Nebulizer
        11.1.4    Mesh Nebulizer  
    11.2    Middle East and Africa Nebulizer Market (2017-2032) by Portability 
        11.2.1    Market Overview
        11.2.2    Digital Nebulizer
        11.2.3    Analog Nebulizer 
    11.3    Middle East and Africa Nebulizer Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Regulatory Framework
13    Patent Analysis

    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Supplier Landscape
    17.1    Adherium 
        17.1.1    Company Overview
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    AstraZeneca 
        17.2.1    Company Overview
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Boehringer Ingelheim International GmbH
        17.3.1    Company Overview
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Cohero Health, Inc.
        17.4.1    Company Overview
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    GSK Group of Companies
        17.5.1    Company Overview
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Teva Pharmaceutical Industries Limited
        17.6.1    Company Overview
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Vectura Group Ltd.
        17.7.1    Company Overview
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Propeller Health
        17.8.1    Company Overview
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Novartis AG
        17.9.1    Company Overview
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    OPKO Health Inc. 
        17.10.1    Company Overview
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    AptarGroup, Inc.
        17.11.1    Company Overview
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Sensirion AG
        17.12.1    Company Overview
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Teleflex Medical, Inc. 
        17.13.1     Company Overview
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Trudell Medical International 
        17.14.1     Company Overview
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Briggs Healthcare  
        17.15.1    Company Overview
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
18    Global Nebulizer Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 1.14 billion in 2023, driven by the growing incidence of respiratory diseases across the globe.

The market is anticipated to grow at a CAGR of 6% during the forecast period of 2024-2032, likely to reach a market value of USD 1.93 billion by 2032.

The market demand is driven by rising prevalence of pollution levels, smoking, rapid industrialisation, and the growing geriatric population. Increasing awareness initiatives, convergence of smart technologies into developing new products and investments by key market players are also fuelling market demand.

The advent of technically advanced products to offer prompt and effective outcomes for patients is a major market trend. In January 2023, Synergy Life Science, Inc., launched Nebi, the first battery operated, rechargeable, pocket sized, and compact nebuliser to be used for multiple respiratory indications.

Based on product types, the market is divided into jet, ultrasonic, and mesh nebulizer.

Common application areas include COPD, cystic fibrosis, asthma, and others.

It includes digital as well as analog nebuliser.

Major end users include hospitals, clinics, and homecare settings, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Adherium, AstraZeneca, Boehringer Ingelheim International GmbH, Cohero Health, Inc., GSK Group of Companies, Teva Pharmaceutical Industries Limited, Vectura Group Ltd., Propeller Health, Novartis AG, OPKO Health Inc., AptarGroup, Inc., Sensirion AG, Teleflex Medical, Inc., Trudell Medical International and Briggs Healthcare.   

Analyst Review

 

 

 

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER